Valuation Methods: Practical Guide to DCF, Comps & Precedents
Valuation is both art and science. Whether valuing a startup, a mature company, or a specific asset, picking the right method and applying it rigorously determines the credibility of your result.
Below is a practical overview of the most widely used valuation methods, their strengths and limitations, and tips to improve accuracy.
Core valuation methods
– Discounted Cash Flow (DCF)
– Essence: Project free cash flows and discount them to present value using an appropriate discount rate, typically WACC for firm-level valuation.
– Strengths: Captures company-specific drivers, useful for forecasting changes in profitability or capital structure.
– Limitations: Highly sensitive to assumptions for growth, margins, and terminal value.
Requires reliable cash-flow forecasts.
– Comparable Company Analysis (Comps)
– Essence: Value a company based on valuation multiples (EV/EBITDA, P/E, Price/Sales) observed for a peer group.
– Strengths: Market-driven, quick to perform, good sanity check against DCF.
– Limitations: Finding true comparables can be difficult; market sentiment can skew multiples.
– Precedent Transactions
– Essence: Use multiples from recent M&A transactions in the same industry as benchmarks.
– Strengths: Reflects real prices paid, including control premiums and synergies.
– Limitations: Transaction data may be scarce or reflect unique strategic buyers and conditions.
– Asset-Based Valuation
– Essence: Sum the fair market value of assets minus liabilities; common for asset-heavy businesses or liquidation scenarios.
– Strengths: Objective when assets are marketable or easily appraised.
– Limitations: Often undervalues operating value for going concerns, ignores intangible drivers like brand or growth potential.
– Residual Income and Dividend Discount Models
– Essence: Value based on dividends (for mature, dividend-paying firms) or economic profit (residual income) when free cash flows are hard to estimate.
– Strengths: Useful for financial institutions or firms with stable payout policies.
– Limitations: Less applicable for companies that reinvest heavily or have erratic payouts.
– Real Options and Scenario Analysis

– Essence: Use option-pricing concepts to value managerial flexibility (e.g., expansion, abandonment) and run multiple scenarios.
– Strengths: Captures strategic value not reflected in static DCFs.
– Limitations: Can be complex and requires careful modeling of volatility and decision timing.
Key adjustments and considerations
– Control vs. Minority: Market prices for control transactions often include premiums; adjust multiples or apply control premiums/minority discounts accordingly.
– Liquidity and Marketability: Thinly traded assets deserve discounts for illiquidity.
– Synergies: In M&A contexts, quantify synergies conservatively and test sensitivity.
– Terminal Value: Often a large portion of DCF; use both perpetuity growth and exit multiple approaches and reconcile results.
– Discount Rate: Calibrate WACC carefully: incorporate capital structure, country risk premia, and sector beta considerations.
Common mistakes to avoid
– Blindly copying peer multiples without normalizing for differences in growth, margins, or capital intensity.
– Overreliance on a single method; best practice is cross-checking multiple approaches.
– Neglecting sensitivity analysis; small changes in discount rates or terminal growth can produce wide valuation bands.
Practical checklist for robust valuation
– Define purpose and valuation perspective (control vs.
minority, market vs. intrinsic).
– Choose at least two complementary methods (e.g., DCF + Comps).
– Normalize historical financials for non-recurring items.
– Run sensitivity and scenario analysis for key assumptions.
– Reconcile differences and present a valuation range, not a single point estimate.
A disciplined blend of methods, transparent assumptions, and rigorous sensitivity testing yields the most defensible valuations. Tailor the approach to the nature of the business and the available market data to arrive at results that withstand scrutiny.